ABVC BIOPHARMA, INC. Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Abvc Biopharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q2 2024.
  • Abvc Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 12.1M shares, a 264% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 12.1M +8.74M +264% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 10.7M -22.4M -67.7% Mar 31, 2024 10-Q 2024-05-17
Q4 2023 7.94M +4.65M +142% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 4.82M -27.8M -85.2% Sep 30, 2023 10-Q 2023-11-15
Q2 2023 3.31M -29M -89.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 33.1M +2.77M +9.15% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 3.29M -21.1M -86.5% Dec 31, 2022 10-K 2024-03-13
Q3 2022 32.6M +4.7M +16.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 32.3M +7.84M +32% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 30.3M +5.89M +24.1% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 24.4M 0 0% Dec 31, 2021 10-K 2023-03-31
Q3 2021 27.9M +7.54M +37% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 24.5M +4.98M +25.6% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 24.4M +4.93M +25.3% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 24.4M +4.94M +25.4% Dec 31, 2020 10-K 2022-03-31
Q3 2020 20.4M +916K +4.7% Sep 30, 2020 10-Q 2020-11-17
Q2 2020 19.5M +1.37M +7.54% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 19.5M +1.79M +10.1% Mar 31, 2020 10-Q 2020-06-30
Q4 2019 19.5M +7.59M +63.9% Dec 31, 2019 10-K 2021-03-16
Q3 2019 19.5M -194M -90.9% Sep 30, 2019 10-Q 2019-11-18
Q2 2019 18.1M -196M -91.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 17.7M -196M -91.7% Mar 31, 2019 10-Q 2019-05-28
Q4 2018 11.9M -202M -94.4% Dec 31, 2018 10-K 2020-05-15
Q3 2018 214M +180K +0.08% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 214M +180K +0.08% Jun 30, 2018 10-Q 2018-08-20
Q1 2018 214M +180K +0.08% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 214M +2.93M +1.39% Dec 31, 2017 10-K 2019-04-15
Q3 2017 214M +2.93M +1.39% Sep 30, 2017 10-KT 2018-04-13
Q2 2017 214M +4.39M +2.1% Jun 30, 2017 10-Q/A 2018-03-19
Q1 2017 214M +4.99M +2.39% Mar 31, 2017 10-Q/A 2018-03-19
Q4 2016 211M +145M +222% Dec 31, 2016 10-Q/A 2018-03-19
Q3 2016 211M +44.5M +26.8% Sep 30, 2016 10-Q/A 2018-03-19
Q2 2016 209M +155M +283% Jun 30, 2016 10-Q/A 2017-02-22
Q1 2016 209M +154M +282% Mar 31, 2016 10-Q/A 2016-05-17
Q4 2015 65.4M +10.8M +19.9% Dec 31, 2015 10-Q 2016-02-23
Q3 2015 166M +166M Sep 30, 2015 10-K/A 2017-09-22
Q2 2015 54.6M 0 0% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 54.6M 0 0% Mar 31, 2015 10-Q/A 2015-06-05
Q4 2014 54.6M 0 0% Dec 31, 2014 10-Q 2015-04-17
Q3 2014 11.1K* -54.6M Sep 30, 2014 10-Q 2016-02-23
Q2 2014 54.6M 0 0% Jun 30, 2014 10-Q 2015-04-17
Q1 2014 54.6M 0 0% Mar 31, 2014 10-Q 2015-04-17
Q4 2013 54.6M 0 0% Dec 31, 2013 10-Q 2015-04-17
Q3 2013 54.6M +40.4M +286% Sep 30, 2013 10-Q 2015-04-17
Q2 2013 54.6M +53.2K +0.1% Jun 30, 2013 10-Q 2015-04-16
Q1 2013 54.6M +38.3M +234% Mar 31, 2013 10-Q 2015-04-16
Q4 2012 54.6M +38.3M +234% Dec 31, 2012 10-Q 2015-04-16
Q3 2012 14.2M 0 0% Sep 30, 2012 10-K 2015-04-16
Q2 2012 54.5M +43.9M +412% Jun 30, 2012 10-Q/A 2012-08-20
Q1 2012 16.3M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 16.3M Dec 31, 2011 10-Q 2012-02-21
Q3 2011 14.2M -18.8M -57% Sep 30, 2011 10-K 2015-04-15
Q2 2011 10.7M Jun 30, 2011 10-Q/A 2011-09-08
Q3 2010 32.9M Sep 30, 2010 10-K/A 2011-12-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.